Loveleen Kang
James A. Haley Veterans' Hospital(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research, Bladder and Urothelial Cancer Treatments, HIV/AIDS drug development and treatment
Most-Cited Works
- → Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer(2007)1,135 cited
- → Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention(2015)126 cited
- → Bladder Cancer: A Review of Non-Muscle Invasive Disease(2010)87 cited
- → Lack of BK virus DNA sequences in most transitional‐cell carcinomas of the bladder(2006)56 cited
- → Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy(2008)52 cited
- → Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms(2011)48 cited
- → Serial Assessment of Lymphocytes and Apoptosis in the Prostate During Coordinated Intraprostatic Dendritic Cell Injection and Radiotherapy(2012)37 cited
- → Immunoreactivity of MIC2 (CD99) and Terminal Deoxynucleotidyl Transferase in Bone Marrow Clot and Core Specimens of Acute Myeloid Leukemias and Myelodysplastic Syndromes(2006)34 cited
- Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.(2010)
- → Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Nonhybrid” (Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-cell Neoplasms(2014)26 cited